Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Solid Biosciences Inc (SLDB)

Solid Biosciences Inc (SLDB)
3.47 -0.20 (-5.45%) 11:11 ET [NASDAQ]
3.45 x 300 3.46 x 173
Realtime by (Cboe BZX)
3.45 x 300 3.46 x 173
Realtime 3.60 -0.07 (-1.91%) 09:04 ET
Profile for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Solid Biosciences Inc 500 RUTHERFORD AVENUE THIRD FLOOR CHARLESTOWN MA 02129 USA

www.solidbio.com Employees: 100 P: 617-337-4680

Sector:

Medical

Description:

Solid Biosciences LLC is a life science company. It focuses on developing therapies for Duchenne muscular dystrophy. The company is engaged in developing gene therapies, disease modifying therapies and assistive devices, all targeting the various facets of the DMD. Its product candidate includes SGT-001, a gene transfer candidate which is in Phase I/II clinical trial to restore functional dystrophin protein expression in patients' muscles. Solid Biosciences LLC is headquartered in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 284,399
Enterprise Value, $K 204,159
Shares Outstanding, K 77,493
Annual Sales, $ 0 K
Annual Net Income, $ -124,700 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -42,600 K
EBIT, $ -129,730 K
EBITDA, $ -130,870 K
60-Month Beta 2.07
% of Insider Shareholders 13.63%
% of Institutional Shareholders 81.46%
Float, K 66,931
% Float 86.37%
Short Volume Ratio 0.56

Growth:

1-Year Return -59.47%
3-Year Return -56.31%
5-Year Return -89.50%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 93.24%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.89 on 03/06/25
Next Earnings Date 05/21/25 [--]
Earnings Per Share ttm -2.93
EPS Growth vs. Prev Qtr -12.66%
EPS Growth vs. Prev Year 11.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 10/28/22

SLDB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -67.74%
Return-on-Assets % -54.51%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.04
Book Value/Share 3.43
Interest Coverage -365.76
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective